Article PDF
References
Grossman W, Jones D, McLaurin LP : Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56: 56–64.
Levy D, Garrison RJ, Savage DD, et al: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.
Katz AM : Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1990; 322: 100–110.
Zou Y, Takano H, Akazawa H, et al: Molecular and cellular mechanisms of mechanical stress–induced cardiac hypertrophy. Endocr J 2002; 49: 1–13.
Frey N, Olson EN : Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003; 65: 45–79.
Heineke J, Molkentin JD : Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7: 589–600.
Opie LH, Commerford PJ, Gersh BJ, et al: Controversies in ventricular remodelling. Lancet 2006; 367: 356–367.
Wollert KC, Taga T, Saito M, et al: Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor–dependent pathways. J Biol Chem 1996; 271: 9535–9545.
Nicol RL, Frey N, Pearson G, et al: Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001; 20: 2757–2767.
Kacimi R, Gerdes AM : Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 2003; 41: 968–977.
Miyamoto T, Takeishi Y, Takahashi H, et al: Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload. Basic Res Cardiol 2004; 99: 328–337.
Weinberg EO, Mirotsou M, Gannon J, et al: Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics 2003; 12: 113–127.
Heymans S, Schroen B, Vermeersch P, et al: Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005; 112: 1136–1144.
Kong SW, Bodyak N, Yue P, et al: Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol Genomics 2005; 21: 34–42.
Zhao M, Chow A, Powers J, et al: Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol Genomics 2004; 19: 93–105.
Rysa J, Leskinen H, Ilves M, et al: Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 2005; 45: 927–933.
Buermans HP, Redout EM, Schiel AE, et al: Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genomics 2005; 21: 314–323.
Miyazaki H, Oka N, Koga A, et al: Comparison of gene expression profiling in pressure and volume overload–induced myocardial hypertrophies in rats. Hypertens Res 2006; 29: 1029–1045.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toko, H., Shiojima, I. & Komuro, I. The Gene Expression Profiling of Concentric and Eccentric Cardiac Hypertrophy. Hypertens Res 29, 941–942 (2006). https://doi.org/10.1291/hypres.29.941
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.941